✦ LIBER ✦

Results of combined hormone therapy in advanced breast cancer

✍ Scribed by Edward F. Lewison; Frances H. Trimble; John L. Grow; Teruo Masukawa

Publisher: John Wiley and Sons
Year: 1963
Tongue: English
Weight: 292 KB
Volume: 16
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(196310)16:10<1243::aid-cncr2820161003>3.0.co;2-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combined estrogenic and androgenic hormo

Combined estrogenic and androgenic hormone therapy in advanced breast cancer

✍ B. J. Kennedy; John H. Brown 📂 Article 📅 1965 🏛 John Wiley and Sons 🌐 English ⚖ 407 KB 👁 1 views

Combination therapy of hormone and cytot

Combination therapy of hormone and cytotoxic agents in advanced breast cancer

✍ David T. Kiang; Daniel H. Frenning; Juliette Gay; Anne I. Goldman; B. J. Kennedy 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 422 KB 👁 2 views

The effectiveness of combination therapy with diethylstilbestrol, cyclophosphamide, and 5-fluorouracil (DES + CTx + FU) was compared with DES alone or CTx + FU in 87 postmenopausal women with advanced breast cancer. Therapy was randomized according to the tumor estrogen-receptor (ER) status. In 30

Hormonal therapy of breast cancer

✍ Albert Segaloff 📂 Article 📅 1972 🏛 John Wiley and Sons 🌐 English ⚖ 205 KB 👁 1 views

Hormone therapy in inoperable breast can

Hormone therapy in inoperable breast cancer

✍ B. J. Kennedy 📂 Article 📅 1969 🏛 John Wiley and Sons 🌐 English ⚖ 405 KB 👁 1 views

Sequential cyclic combined hormonal ther

Sequential cyclic combined hormonal therapy for metastatic breast cancer

✍ Gabriel N. Hortobagyi; Verena Hug; Aman U. Buzdar; Shu W. Kau; Frankie A. Holmes 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 454 KB 👁 1 views

Combined cytotoxic and progestogen thera

Combined cytotoxic and progestogen therapy for advanced breast cancer

✍ Robert D. Rubens; Richard H. J. Begent; Robert K. Knight; Sheila A. Sexton; John 📂 Article 📅 1978 🏛 John Wiley and Sons 🌐 English ⚖ 453 KB 👁 1 views

Sixty-nine patients with advanced breast cancer treated with cytotoxic chemotherapy were randomized to receive concomitantly either norethisterone acetate (progestogen group) or a placebo (placebo group). Objective responses were seen in 53% of patients in the progestogen group and 61% of patients i